Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis

Gene

Volumn 579, Issue 1, 2016, Pages 29-33

  Louka, Manal L ^a   Ramzy, Maggie M ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Minia University   (Egypt)

Author keywords

Fibrosis; Liver; Marker; MMP 13; Resolution; S100A4

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALVASCULIN; CARBON TETRACHLORIDE; COLLAGENASE 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; MMP13 PROTEIN, RAT; PROTEIN S 100; S100A4 PROTEIN, RAT; TGFB1 PROTEIN, RAT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; FIBROGENESIS; LIVER FIBROSIS; LIVER LEVEL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BLOOD; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ANIMALS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 13; RATS; S100 PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84958884015     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.12.042     Document Type: Article

References (46)

1. Andersen K., Mori H., Fata J., Bascom J., Øyjord T., Mælandsmo G.M., Bissell M. The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis. Dev. Biol. 2011, 352:181-190.
2. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115(2):209-218.
3. Bjork P., Kallberg E., Wellmar U., Riva M., Olsson A., He Z., et al. Common interactions between S100-A4 and S100A9 defined by a novel chemical probe. PLoS One 2013, 8:e63012.
4. Boye K., Nesland J.M., Sandstad B., Maelandsmo G.M., Flatmark K. Nuclear S100A4 is a novel prognostic marker in colorectal cancer. Eur. J. Cancer 2010, 46:2919-2925.
5. Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976, 72:248-251.
6. Chen L., Li J., Zhang J., Dai C., Liu X., Wang J., Gao Z., Guo H., Wang R., Lu S., Wang F., Zhang H., Chen H., Fan X., Wang S., Qin Z. S100A4 promotes liver fibrosis via activation of hepatic stellate cells. J. Hepatol. 2015, 62(1):156-156.
7. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
8. Elenjord R., Ljones H., Sundkvist E., Loennechen T., Winberg J.O. Dysregulation of matrix metalloproteinases and their tissue inhibitors by S100A4. Connect. Tissue Res. 2008, 49:185-188.
9. Elenjord R., Allen J.B., Johansen H.T., Kildalsen H., Svineng G., Maelandsmo G.M., Loennechen T., Winberg J.O. Collagen I regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4. FEBS J. 2009, 276(18):5275-5286.
10. Ellis E.L., Mann D.A. Clinical evidence for the regression of liver fibrosis. J. Hepatol. 2012, 56(5):1171-1180.
11. Fallowfield J.A., Mizuno M., Kendall T.J., Constandinou C.M., Benyon R.C., Duffield J.S., Iredale J.P. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 2007, 178:5288-5295.
12. Friedman S.L. Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol. 2010, 7(8):425-436.
13. Friedman S.L., Sheppard D., Duffield J.S., Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci. Transl. Med. 2013, 5(167):1-17.
14. Hayashi H., Sakai T. Biological significance of local TGF-β activation in liver diseases. Front. Physiol. 2012, 3:12. 10.3389/fphys.2012.00012.
15. Hironaka K., Sakaida I., Matsumara Y., Kaino S., Miyamoto K., Okita K. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cells by gadolinium chloride prevents pig serum-induced rat liver fibrosis. Biochem. Biophys. Res. Commun. 2000, 267:290-295.
16. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 2007, 117:539-548.
17. Iredale J.P., Benyon R.C., Arthur M.J., Ferris W.F., Alcolado R., Winwood P.J., Clark N., Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996, 24:176-184.
18. Iredale J.P., Thompson A., Henderson N.C. Extracellular matrix degradation in liver fibrosis: biochemistry and regulation. Biochim. Biophys. Acta 2013, 1832(7):876-883.
19. Issa R., Williams E., Trim N., Kendall T., Arthur M.J., Reichen J., Benyon R.C., Iredale J.P. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001, 48:548-557.
20. Issa R., Zhou X., Constandinou C.M., Fallowfield J., Millward-Sadler H., Gaca M.D., et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004, 126:1795-1808.
21. Iwano M., Fischer A., Okada H., Plieth D., Xue C., Danoff T.M., et al. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol. Ther. 2001, 3:149-159.
22. Lawson W.E., Polosukhin V.V., Zoia O., Stathopoulos G.T., Han W., Plieth D., et al. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2005, 171:899-907.
23. Liu Z., Liu H., Pan H., Du Q., Liang J. Clinico-pathological significance of S100A4 expression in human hepatocellular carcinoma. J. Int. Med. Res. 2013, 41(2):457-462.
24. Miranda K.J., Loeser R.F., Yammani R.R. Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13. J. Biol. Chem. 2010, 285:31517-31524.
25. Osterreicher C.H., Penz-Osterreicher M., Grivennikov S.I., Guma M., Koltsova E.K., Datz C., et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl. Acad. Sci. 2011, 108:308-313.
26. Pellicoro A., Ramachandran P., Iredale J.P., Fallowfield J.A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 2014, 14(3):181-194.
27. Popov Y., Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009, 50(4):1294-1306.
28. Ramachandran P., Iredale J.P. Liver fibrosis: a bidirectional model of fibrogenesis and resolution. QJM 2012, 105(9):813-817.
29. Ramachandran P., Pellicoro A., Vernon M.A., Boulter L., Aucott R.L., Ali A., et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3186-E3195.
30. Reitman S., Frankel S. A colourimetric method for the determination of glutmate-oxaloacetate and glutmate-pyruvate transaminase. J. Clin. Pathol. 1957, 28(56).
31. Schneider M., Kostin S., Strøm C.C., Aplin M., Lyngbæk S., Theilade J., Grigorian M., Andersen C.B., Lukanidin E., Lerche Hansen J., Sheikh S.P. S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc. Res. 2007, 75(1):40-50.
32. Schuppan D., Kim Y.O. Evolving therapies for liver fibrosis. J. Clin. Invest. 2013, 123:1887-1901.
33. Schuppan D., Pinzani M. Anti-fibrotic therapy: lost in translation?. J. Hepatol. 2012, 56(Suppl. 1):S66-S74.
34. Tacke F., Trautwein C. Mechanisms of liver fibrosis resolution. J. Hepatol. 2015, 10.1016/j.jhep.2015.03.039.
35. Tomcik M., Andres Cerezo L., Skacelova S., Komarc M., Becvar R., Grigorian M., et al. A3.16 serum S100-A4 correlates with skin fibrosis, lung involvement and disease activity in systemic sclerosis. Ann. Rheum. Dis. 2014, 73:A48.
36. Uchinami H., Seki E., Brenner D.A., D'Armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006, 44(2):420-429.
37. van Dieck J., Fernandez-Fernandez M.R., Veprintsev D.B., Fersht A.R. Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J. Biol. Chem. 2009, 284(20):13804-13811.
38. Van Guilder H.D., Vrana K.E., Freeman W.M. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008, 44:619-626.
39. Varga J., Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 2007, 117:557-567.
40. Watanabe T., Niioka M., Hozawa S., Kameyama K., Hayashi T., Arai M., Ishikawa A., Maruyama K., Okazaki I. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J. Hepatol. 2000, 33:224-235.
41. Watanabe T., Niioka M., Hozawa S., Sugioka Y., Arai M., Maruyama K., Okano H., Okazaki I. Stem cells expressing MMP-13 mRNA appear during regression reversal of hepatic cirrhosis. Extracellular Matrix and the Liver: Approach to Gene Therapy 2003, 361-388. Academic Press, New York. I. Okazaki, Y. Ninomiya, S.L. Friedman, K. Tanikawa (Eds.).
42. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18(7):1028-1040. (6).
43. Yammani R.R., Carlson C.S., Bresnick A.R., Loeser R.F. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum. 2006, 54:2901-2911.
44. Ye H.Q., Maeda M., Yu F.X., Azar D.T. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest. Ophthalmol. Vis. Sci. 2000, 41(10):2894-2899.
45. Yoshimatsu Y., Watabe T. Roles of TGF-β signals in endothelial-mesenchymal transition during cardiac fibrosis. Int. J. Inflamm. 2011, 724080. (Epub 2011 Nov 30). 10.4061/2011/724080.
46. Zhang J., Chen L., Xiao M., Wang C., Qin Z. FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation. Am. J. Pathol. 2011, 178:382-390.